Superworth

Calidi Biotherapeutics price to book ratio CLDI

Market value divided by the book value of the company's net assets, since 2025.

Today, Nov 2, 2026
0.5×
Peer median
0.4×

Calidi Biotherapeutics' price to book ratio is 0.5× as of Nov 2, 2026.

The median for 3 healthcare stocks of a similar size is 0.4×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.5×0.3×1.3×
20251.3×1.0×10.3×

Against its peers

Companies in Healthcare nearest Calidi Biotherapeutics' size, closest first, today.

CompanyPrice to book ratio
CLDICalidi Biotherapeutics0.5×
OXBROXBRIDGE RE HOLDINGS1.0×
EDUCEducational Development0.2×
GTIMGood Times Restaurants0.4×
Peer median0.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Calidi Biotherapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.